<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Myriam Sneyers</style></author><author><style face="normal" font="default" size="100%">Dumon,J.C.</style></author><author><style face="normal" font="default" size="100%">Bernadette Van Vaerenbergh</style></author><author><style face="normal" font="default" size="100%">William Moens</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Gene therapy clinical trials in Belgium</style></title><secondary-title><style face="normal" font="default" size="100%">Hum.Gene Ther.</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Belgium</style></keyword><keyword><style  face="normal" font="default" size="100%">biosafety</style></keyword><keyword><style  face="normal" font="default" size="100%">Biotechnology</style></keyword><keyword><style  face="normal" font="default" size="100%">Brussels</style></keyword><keyword><style  face="normal" font="default" size="100%">clinical trial</style></keyword><keyword><style  face="normal" font="default" size="100%">Clinical trials</style></keyword><keyword><style  face="normal" font="default" size="100%">Database</style></keyword><keyword><style  face="normal" font="default" size="100%">European</style></keyword><keyword><style  face="normal" font="default" size="100%">European Union</style></keyword><keyword><style  face="normal" font="default" size="100%">gene</style></keyword><keyword><style  face="normal" font="default" size="100%">gene therapy</style></keyword><keyword><style  face="normal" font="default" size="100%">health</style></keyword><keyword><style  face="normal" font="default" size="100%">INFORMATION</style></keyword><keyword><style  face="normal" font="default" size="100%">Institute</style></keyword><keyword><style  face="normal" font="default" size="100%">Paper</style></keyword><keyword><style  face="normal" font="default" size="100%">public</style></keyword><keyword><style  face="normal" font="default" size="100%">public health</style></keyword><keyword><style  face="normal" font="default" size="100%">Public-health</style></keyword><keyword><style  face="normal" font="default" size="100%">Regulatory</style></keyword><keyword><style  face="normal" font="default" size="100%">SBB</style></keyword><keyword><style  face="normal" font="default" size="100%">Service</style></keyword><keyword><style  face="normal" font="default" size="100%">Therapy</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2001</style></year><pub-dates><date><style  face="normal" font="default" size="100%">0/0/2001</style></date></pub-dates></dates><number><style face="normal" font="default" size="100%">1365</style></number><volume><style face="normal" font="default" size="100%">12</style></volume><pages><style face="normal" font="default" size="100%">1361 - 1365</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">The present paper briefly describes the missing information about gene therapy clinical trials authorized in Belgium in relation with the regulatory framework. It also proposes a basic database format, complying with legal confidentiality rules. We then discuss transparency in the gene therapy field within the European Union.</style></abstract><issue><style face="normal" font="default" size="100%">10</style></issue><custom1><style face="normal" font="default" size="100%">2819</style></custom1><section><style face="normal" font="default" size="100%">1361</style></section></record></records></xml>